Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)

Current Hematologic Malignancy Reports - United States
doi 10.1007/s11899-015-0295-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Chronic Lymphocytic Leukaemia

Nature Reviews Disease Primers
Medicine
2017English

A Phase II Trial of Eltrombopag for Patients With Chronic Lymphocytic Leukaemia (CLL) and Thrombocytopenia

British Journal of Haematology
Hematology
2018English

DNA Methylation Signatures in Chronic Lymphocytic Leukemia (CLL)

Science-Business eXchange
2012English

Cost-Effectiveness of Ibrutinib in Patients With Relapsed or Refractory (RR) Chronic Lymphocytic Leukaemia (CLL) in England

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Cd160 Expression in B Chronic Lymphocytic Leukemia (B-Cll.).

International Journal of Advanced Research
2017English

Low-Dose Subcutaneous Alemtuzumab in Refractory Chronic Lymphocytic Leukaemia (CLL): Results of a Prospective, Single-Arm Multicentre Study

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Acute Renal Failure With Chronic Lymphocytic Leukaemia.

Postgraduate Medical Journal
Medicine
1996English

Stomach Cancer in a Patient With Chronic Lymphocytic Leukaemia

Creative surgery and oncology
2019English

The Prognostic Significance of Cytopenia in Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma

British Journal of Haematology
Hematology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy